miRNA General Information
miRNA Mature ID hsa-miR-302a-3p
miRNA Stemloop AC MI0000738
miRNA Stemloop ID hsa-mir-302a
Sequence uaagugcuuccauguuuugguga
TTD Target(s) Regulated by This miRNA Cyclin-dependent kinase 4 (CDK4) Successful Target Target Info [1]
ATP-binding cassette transporter A1 (ABCA1) Successful Target Target Info [2]
RAC-alpha serine/threonine-protein kinase (AKT1) Successful Target Target Info [3]
Cyclin-dependent kinase 1 (CDK1) Clinical trial Target Target Info [4]
Cyclin-dependent kinase 2 (CDK2) Clinical trial Target Target Info [5]
G1/S-specific cyclin-D1 (CCND1) Clinical trial Target Target Info [6]
MAPK/ERK kinase kinase 1 (MAP3K1) Clinical trial Target Target Info [7]
Syndecan-1 (SDC1) Clinical trial Target Target Info [8]
Phosphatase and tensin homolog (PTEN) Literature-reported Target Target Info [9]
Polycomb complex protein BMI-1 (BMI1) Clinical trial Target Target Info [5]
Melanoma differentiation-associated protein 6 (CDKN1A) Literature-reported Target Target Info [10]
Protein(s) Regulated by This miRNA COUP transcription factor 2 Regulated Protein [11]
DAZ-associated protein 2 Regulated Protein [12]
GRB2-associated-binding protein 2 Regulated Protein [13]
Homeobox protein NANOG Regulated Protein [14]
Left-right determination factor 1 Regulated Protein [15]
Left-right determination factor 2 Regulated Protein [15]
Methyl-CpG-binding domain protein 2 Regulated Protein [14]
Protachykinin-1 Regulated Protein [16]
Protein Tob2 Regulated Protein [12]
SLAIN motif-containing protein 1 Regulated Protein [12]
References
REF 1 Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol. 2008 Oct;28(20):6426-38.
REF 2 MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis. Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):323-31.
REF 3 The microRNA-302-367 cluster suppresses the proliferation of cervical carcinoma cells through the novel target AKT1. RNA. 2013 Jan;19(1):85-95.
REF 4 MicroRNA miR-302 inhibits the tumorigenicity of endometrial cancer cells by suppression of Cyclin D1 and CDK1. Cancer Lett. 2014 Apr 1;345(1):39-47.
REF 5 Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells. Oncogenesis. 2014 May 26;3:e104.
REF 6 MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res. 2008 May;18(5):549-57.
REF 7 MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1). J Exp Clin Cancer Res. 2016 Feb 3;35:25.
REF 8 MiR-302a inhibits the tumorigenicity of ovarian cancer cells by suppression of SDC1. Int J Clin Exp Pathol. 2015 May 1;8(5):4869-80.
REF 9 miR-302 Attenuates Amyloid--Induced Neurotoxicity through Activation of Akt Signaling. J Alzheimers Dis. 2016;50(4):1083-98.
REF 10 Multiple microRNAs rescue from Ras-induced senescence by inhibiting p21(Waf1/Cip1). Oncogene. 2010 Apr 15;29(15):2262-71.
REF 11 A regulatory circuitry comprised of miR-302 and the transcription factors OCT4 and NR2F2 regulates human embryonic stem cell differentiation.EMBO J. 2011 Jan 19;30(2):237-48.
REF 12 Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response.Genes Dev. 2011 Oct 15;25(20):2173-86.
REF 13 MicroRNA-302a targets GAB2 to suppress cell proliferation, migration and invasion of glioma.Oncol Rep. 2017 Feb;37(2):1159-1167.
REF 14 Epigenetic regulation of NANOG by miR-302 cluster-MBD2 completes induced pluripotent stem cell reprogramming.Stem Cells. 2013 Apr;31(4):666-81.
REF 15 The Nodal inhibitor Lefty is negatively modulated by the microRNA miR-302 in human embryonic stem cells.FASEB J. 2011 May;25(5):1497-508.
REF 16 MicroRNAs regulate synthesis of the neurotransmitter substance P in human mesenchymal stem cell-derived neuronal cells.Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15484-9.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.